Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Senda Biosciences
Sail Biomedicines is at the forefront of programmable medicines, leveraging AI and a proprietary bioplatform to create life-changing treatments. Their core technology revolves around Endless RNA…
Senda Biosciences
Sail Biomedicines is at the forefront of programmable medicines, leveraging AI and a proprietary bioplatform to create life-changing treatments. Their core technology revolves around Endless RNA…
TL;DR
Founded: 2017
Headquarters: Cambridge, Massachusetts
Core focus: Therapeutics platform exploring molecular relationships between bacterial, botanical, and human cells
Recent notable financing: Series C $123M (Aug 16, 2022)
Acquisition / merger activity: Acquired Kintai Therapeutics (2020); merged into/acquired by Sail Biomedicines (announced Oct 19, 2023)
Company Overview
Problem Domain
Therapeutics discovery and delivery leveraging molecular interactions across bacterial, botanical, and human cells
Founded
2017
Industry
Biotechnology / Therapeutics
Funding Track Record
$123,000,000
Series C announced Aug 16, 2022
Investor Signal
“Flagship Pioneering, Alexandria Venture Investments, Samsung Life Science Fund, Mayo Clinic, Longevity Vision Fund, Qatar Investment Authority (reported investors across rounds)”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,400+
New This Week